INTRODUCTION
Malignant fibrous histiocytoma (MFH) is a rare primary neoplasm occurring in the bone; according to Mayo Clinic files, it accounts for less than 1% of primary bone tumors (1, 2) . The neoplasm is found most frequently in the long tubular bones of the lower extremities (1) . Only rare cases arising in the skull have been published (3) (4) (5) (6) , and the majority of the patients had large lytic areas of bone destruction with extensions to the adjacent soft tissue, underlying dura, or brain parenchyma. We experienced a rare case of primary MFH involving only a cranial vault with no extraosseous extensions in a 43-yr-old woman. This is an unusual presentation of MFH.
CASE REPORT
A 43-yr-old woman was admitted because of a palpable mass in the right parietal region, which had enlarged in size over the preceding 15 months. A physical examination revealed tender swelling in the right parietal region. She had a history of trauma in the same site 15 yr ago and no history of irradiation. There was no evidence of soft tissue mass or concurrent illness. A plain skull radiograph showed a well-defined lytic defect, measuring 5 cm in diameter in the right parietal area (Fig. 1A) . Computerized tomographic (CT) scanning demonstrated an area of extensive lytic bony destruction with little discernible residual cortex and no significant periosteal reaction. The margins were well delineated, and there was no matrix formation within the lesion (Fig. 1B) . T1-weighted magnetic resonance (MR) images showed a pancake-shaped, slightly low signal intensity mass with central nodularity, which exhibited heterogeneous and slightly high signal intensity on T2-weighted images and was well enhanced on contrast-enhanced MR images. No evidence of extensions to the adjacent soft tissue and underlying dura mater was noted (Fig. 1C-F) . We suspected a benign osseous lesion, such as intraosseous meningioma or eosinophilic granuloma, because of the less aggressive radiological features, and a wide excision of the parietal bone was performed. On operative findings, the tumor was well distinguished from the nontumorous bone and was easily detached from the underlying dura or the adjacent muscle.
The resected specimen was a solid, disk-shaped lesion yellowish-brown in color and measuring 5×4×1 cm. It showed a more nodular round area, corresponding to the nodular signal pattern in the MR images. Histologically, the tumor consisted of atypical spindle cells arranged in a storiform or fascicular pattern (Fig. 2) . The tumor cells showed high degree of pleomor-
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phism with abundant eosinophilic cytoplasm and occasional multinucleation, and abundant typical or atypical mitotic figures (Fig. 3) . To exclude the possibility of MFH-like osteosarcoma, we thoroughly searched for a tumor osteoid, but failed to find it. Immunohistochemical staining revealed positive reactivity for vimentin, -1-antitrypsin, and p53. There was no immunoreactivity for smooth muscle actin, S100 protein, desmin, MyoD1, and cytokeratin.
Postoperatively, the patient underwent radiotherapy of 6120 cGy. Three months later, a progressive swelling was palpable in the previously operated site. Follow-up MR images done at that time demonstrated a subcutaneous fluid collection with peripheral enhancement. A percutaneous needle aspiration was subsequently performed. The cytologic findings of the aspiration fluid obtained from the recurrent cystic lesion revealed some scattered pleomorphic large cells in the background of abundant inflammatory cells. These atypical cells frequently showed binucleated or multinucleated forms with abundant (Fig. 4) . Thereafter, the patient received another operation, and the lesion was histologically confirmed to be the recurrent tumor.
DISCUSSION
Although many cases of MFH in soft tissues have been reported, the descriptions of their occurrences in bony areas are rare (1, 2, 7-9), and extremely rare in the skull. The mandibulomaxillary area was the most common site for MFH in the skull (3-4), followed by the calvarium. We found eight cases of MFH in the calvarium (5-6): in the frontal bone and temporal bone (two patients each); and in the frontotemporal bone, occipital bone, parietal bone, and clivus (one patient each). The patients' ages ranged from 25 to 72 yrs old. There were five males and three females. Most of them had rapidly enlarging painless masses on the skull, as in the present case. 
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In addition to its unusual location, the radiologic findings of the present case were unique. At initial presentation, the lesion was confined to the cranial bone with no definite evidence of extraosseous (adjacent soft tissue, dura mater, or brain parenchyma) extensions. Typical radiologic findings of MFH include purely osteolytic, aggressive, destructive tumor growth with frequent soft tissue involvement, and periosteal reactions and expansile growth were rarely seen (10, 11) . In all reported cases arising in the skull, the tumors involved all layers with inward and/or outward extensions and were sometimes presented as an intracranial or a soft tissue mass (5, 6) . In our case, some favorable findings to benign lesions were apparent; the tumor size was not small, but placed horizontally along the cranial vault, and it displayed good localization with no definite extraosseous extensions. Considering the case retrospectively, extensive osteolysis with cortical destruction as well as an inhomogeneous nodular signal pattern on T2-weighted and contrast-enhanced T1-weighted MR images were suggestive of a malignant osseous lesion.
Before making a diagnosis of MFH, the exclusion of other types of pleomorphic sarcoma with dedifferentiated areas is mandatory because their histologic appearance is akin to MFH (1, 2, 12, 13) . The marked pleomorphism with multinucleated giant cells and a storiform pattern observed in the present case were consistent with the characteristic histological findings of MFH. Moreover, differentiation to specific cells, such as smooth muscle cells, skeletal muscle cells, or fat cells, was not detected immunohistochemically, and there was no tumor osteoid suggestive of bone-forming tumor throughout the lesion. Naka et al. (13) reported that no overexpressions of the p53 protein were found in the MFH-like osteosarcoma, whereas it tended to occur more frequently in MFH of the bone. In our case, a significant overexpression of the p53 protein was demonstrated.
At the first time of recurrence, the lesion was predominantly cystic with only peripheral enhancement. We thought that this lesion had to be discriminated from the retained hematoma, and then we first performed the percutaneous aspiration cytology, which revealed diagnostic tumor cells. Multinucleated bizarre nuclei and abundant cytoplasm are thought to be characteristic cytologic findings for identifying the histiocytic features of this tumor. Although the final diagnosis of the recurrent tumor relied on the histologic findings, the cytologic examination was helpful as an auxiliary study in our case.
All reported patients underwent gross total removal of the tumor; nevertheless, the prognosis is poor, similar to MFHs occurring in the other sites of the body (1, 2, 8, 12, 14) . Our patient received wide resection of the affected skull bone with the adjacent dura and soft tissue followed by irradiation, and we expected a hopeful outcome considering the less aggressive presentation of the tumor. However, the patient had to receive repetitive resections of recurrent or residual lesions, and she died of postoperative meningoencephalitis two years after the first operation. We believe that adjuvant chemotherapy would have been necessary for this patient, as previous report stressed the usefulness of chemotherapy (14) .
